Darunavir

Darunavir has been studied in 1 paper since 2022: 1 observational study in people. The newest paper, Jun 28, 2016: “Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s”.

1 paper studies it7 more mention itUpdated Dec 12, 2022

Humans1

Latest

Aging CellDec 22

Antiretroviral protease inhibitors induce features of cellular senescence that are reversible upon drug removal

Experiments in cellsInterventions

Journal of NeurovirologyDec 13

Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study

Cohort study in peopleNeurological disorders

The Lancet HIVApr 2

Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial

Trial in peopleBiomarkers

Clinical Infectious DiseasesJul 18

Telomere Length, Traditional Risk Factors, Factors Related to Human Immunodeficiency Virus (HIV) and Coronary Artery Disease Events in Swiss Persons Living With HIV

Study in peopleBiomarkers

AIDSFeb 7

Aging does not impact drug--drug interaction magnitudes with antiretrovirals

Trial in peopleInterventions

HIV MedicineSep 18

Determinants of blood telomere length in antiretroviral treatment-naïve HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial

Study in peopleBiomarkers

Antiviral TherapyMar 30

Impact of CCR5, integrase and protease inhibitors on human endothelial cell function, stress, inflammation and senescence

Experiments in cellsInterventions

The Journal of Infectious DiseasesJun 30

Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s

Trial in peopleInterventions